Suivre
Abonner Abcam plc

Abcam plc

Filtre
  • 20.07.2022 – 15:11

    ABCAM PLC First Half Trading Update

    Cambridge, England (ots/PRNewswire) - Abcam plc ("Abcam", "Company", "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following trading update for the six-month period ending 30 June 2022. The Company will release its full results for the six-month period on 12 September 2022. The Group expects to report total revenues for the six-month period of ...

  • 27.06.2022 – 08:01

    Abcam: Appointment of Vice President of Investor Relations

    Cambridge, England (ots/PRNewswire) - Abcam plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations. Tommy, who will be based in our Waltham, MA office, has over 20 years' experience in the life sciences sector, largely focused in the area of research tools. He joins ...

  • 28.03.2022 – 13:35

    Abcam the most awarded company at 2022 industry awards

    Cambridge, England (ots/PRNewswire) - CAMBRIDGE, England, March 25, 2022 Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia and industry to advance ...

  • 27.10.2021 – 08:01

    Abcam completes $340m strategic acquisition and expands kit capacity and capability

    Cambridge, England (ots/PRNewswire) - - Completing $340m strategic acquisition of BioVision - Expanding facilities in Eugene, further growing kits and assays portfolio - Supporting the growing demand of the sector and accelerating execution of strategic plan Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the ...

  • 13.07.2021 – 13:00

    Abcam opens new US facility in Boston, MA

    Cambridge (ots/PRNewswire) - Supporting accelerated growth of R&D, manufacturing, and commercial activities with new 100,000 sq-ft state-of-the-art facility Reinforcing commitment to the region as Abcam approaches 20 years of US presence Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA. The new facility is a central ...

  • 08.12.2020 – 13:00

    Abcam reveals new cell engineering facility in Bay Area

    Cambridge, England (ots/PRNewswire) - - State-of-the-art site will enable rapid delivery of engineered cell lines - Powering ready-to-use edited cell-line portfolio expansion - Enable comprehensive customization for research, diagnostic and therapeutic development Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced the opening of a new 16,000 sq ft purpose-fitted facility ...